APA (7th ed.) Citation

Sattler, A., Schrezenmeier, E., Weber, U. A., Potekhin, A., Bachmann, F., Straub-Hohenbleicher, H., . . . Kotsch, K. (2021). Impaired humoral and cellular immunity after SARS-CoV-2 BNT162b2 (tozinameran) prime-boost vaccination in kidney transplant recipients. The journal of clinical investigation, 131(14), . https://doi.org/10.1172/JCI150175

Chicago Style (17th ed.) Citation

Sattler, Arne, et al. "Impaired Humoral and Cellular Immunity After SARS-CoV-2 BNT162b2 (tozinameran) Prime-boost Vaccination in Kidney Transplant Recipients." The Journal of Clinical Investigation 131, no. 14 (2021). https://doi.org/10.1172/JCI150175.

MLA (9th ed.) Citation

Sattler, Arne, et al. "Impaired Humoral and Cellular Immunity After SARS-CoV-2 BNT162b2 (tozinameran) Prime-boost Vaccination in Kidney Transplant Recipients." The Journal of Clinical Investigation, vol. 131, no. 14, 2021, https://doi.org/10.1172/JCI150175.